Redefining Pre-Clinical Testing

Cellverse creates AI powered digital twins of human diseases and invitro disease models aiding in safer, faster, sustainable and scientific drug discovery

Partner with us Explore our products

Cellverse

About Cellverse

At Cellverse we develop an integrating AI-powered Digital Twins, bioinks, in-vitro tissue models and the data governance platform that creates predictive representations of human tissues and disease so that the next generation of drugs, devices, and clinical decisions is built on biology that actually reflects the patient it is meant to serve.

Our Mission

We aim to reduce reliance on animal testing, accelerate biomedical innovation, and advance a future where therapies are developed using models that more accurately reflect human biology.

Collaborations & Incubations

Our Products

Physiologically Grounded Models for Predictive Clinical Intelligence

Digital Twins

Computational representations of individual patient anatomy and disease burden, enabling clinicians to simulate, compare, and optimize treatment strategies before the first incision.

Our Products

Advanced Platforms for Medicine & Biology

Hospitals • Research Networks • Healthcare Systems

Digital Twins

Physiologically Grounded Models for Predictive Clinical Intelligence

Computational representations of individual patient anatomy and disease burden, enabling clinicians to simulate, compare, and optimize treatment strategies before the first incision.

Disease progressionPatient responseAPI access

Research Labs • Biotech • CROs

AI-Optimized Bioinks & Bioprinters

Precision-Engineered Biomaterials for 3D Tissue Fabrication

AI-optimised hydrogel bio-inks formulated for reproducible 3D bioprinting across research and preclinical applications. Produced in controlled batches and delivered in ready-to-use units, paired with a proprietary bioprinter designed for institutional research workflows.

AI-OptimizedCell viabilityBiocompatible

Pharma R&D • CROs • Research Institutions

In-Vitro Disease Models

Validated 3D Tissue Kits for Drug Discovery and Preclinical Research

Engineered tissue constructs that replicate human disease biology without animal models. Current portfolio covers skin disease and oral cancer — the latter with no direct global competitor at this specification — delivered as standardised kits for pharma, CRO, and academic customers.

StandardizedHigh-throughputAssay-ready

Pharma • Biotech • Computational Research

Medtech Data centre governance platform

Clinical Data Infrastructure for AI-Ready Healthcare Institutions

Enterprise software that standardises, secures, and governs biomedical and clinical data across hospital and research institution environments. Built to meet DPDP Act requirements in India and aligned with international data governance frameworks for institutions preparing for AI adoption at scale.

InteroperabilityComplianceData Security